Clene Inc. secures additional NIH grant funds for ALS therapy

Go back to Clene Inc. secures additional NIH grant funds for ALS therapy
(NASDAQ: CLNN) Delayed: 3.94 +0.10 (2.60%)
Previous Close $3.84    52 Week High $ 
Open $3.84    52 Week Low $ 
Day High $3.97    P/E N/A 
Day Low $3.84    EPS $ 
Volume 8,226